Co-occurrence of MS and ALS: a clue in favor of common pathophysiological findings?

被引:5
作者
Guennoc, Anne-Marie [1 ]
Pallix-Guyot, Maud [2 ]
Le Page, Emmanuelle [3 ]
Le Port, Damien [3 ]
Daryabin, Mathieu [4 ]
Hergesheimer, Rudolph [1 ]
Beltran, Stephane [1 ,5 ]
Tourbah, Ayman [6 ]
Edan, Gilles [3 ]
Corcia, Philippe [1 ,5 ]
机构
[1] Univ Hosp Ctr Tours, Neurol Dept, Tours, France
[2] Reg Hosp Ctr Orleans, Neurol Dept, Orleans, France
[3] Univ Hosp Ctr Rennes, Neurol Dept, Rennes, France
[4] Hosp Ctr Angouleme, Neurol Dept, Angouleme, France
[5] Univ Hosp Ctr Tours, ALS Ctr, Tours, France
[6] Univ Hosp Ctr Reims, Neurol Dept, Reims, France
关键词
Amyotrophic lateral sclerosis; multiple sclerosis; co-occurrence; AMYOTROPHIC-LATERAL-SCLEROSIS; MULTIPLE-SCLEROSIS;
D O I
10.1080/21678421.2018.1476547
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS) are two neurological disorders that seem, theoretically, completely divergent according to epidemiological, clinical, pathophysiological, and therapeutic data. However, some reports that have mentioned the occurrence of both conditions within the same patient underpin the suggestion that this co-occurrence might not be random. We report six co-occurrences of ALS and MS cases, focusing on epidemiological and clinical diseases findings. We then compare our cohort to those in the literature. Our cohort was composed of five females and one male. The age of onset for MS ranged from 27 to 54 years with either primary or secondary prominence while all being progressive. Both diseases occurred sequentially in all but one the cases. Concerning ALS, the age of onset ranged from 51 to 60 years and the site of onset was the legs in 5/6 cases. The disease lasted from four to 29 months. Although infrequent, this co-occurrence supports the hypothesis of common, pathophysiological mechanisms between ALS and MS. We discuss some arguments favoring a potential link between both conditions.
引用
收藏
页码:500 / 505
页数:6
相关论文
共 20 条
[1]   Muscle atrophy associated with multiple sclerosis: A benign condition or the onset of amyotrophic lateral sclerosis? [J].
Allen, Jeffrey A. ;
Stein, Robert ;
Baker, Richard A. ;
Jones, H. Royden .
JOURNAL OF CLINICAL NEUROSCIENCE, 2008, 15 (06) :706-708
[2]  
Borisow N, 2013, BMJ CASE REP, V23, P2013
[3]  
CONFAVREUX C, 1993, REV NEUROL, V149, P351
[4]   Multiple sclerosis and amyotrophic lateral sclerosis: a human leukocyte antigen challenge [J].
Dattola, Vincenzo ;
Fama, Fausto ;
Russo, Margherita ;
Calabro, Rocco Salvatore ;
Logiudice, Anna Lisa ;
Grasso, Maria Grazia ;
Patti, Francesco ;
Buccafusca, Maria .
NEUROLOGICAL SCIENCES, 2017, 38 (08) :1501-1503
[5]   Amyotrophic lateral sclerosis with multiple sclerosis: A clinical and pathological report [J].
Dynes, GJ ;
Schwimer, CJ ;
Staugaitis, SM ;
Doyle, JJ ;
Hays, AP ;
Mitsumoto, H .
AMYOTROPHIC LATERAL SCLEROSIS, 2000, 1 (05) :349-353
[6]   Multiple sclerosis and amyotrophic lateral sclerosis: is there a link? [J].
Etemadifar, Masoud ;
Abtahi, Seyed-Hossein ;
Akbari, Mojtaba ;
Maghzi, Amir-Hadi .
MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (06) :902-904
[7]   T-cell-mediated regulation of neuroinflammation involved in neurodegenerative diseases [J].
Gonzalez, Hugo ;
Pacheco, Rodrigo .
JOURNAL OF NEUROINFLAMMATION, 2014, 11
[8]   THE CONCURRENCE OF MULTIPLE-SCLEROSIS AND AMYOTROPHIC-LATERAL-SCLEROSIS [J].
HADER, WJ ;
ROZDILSKY, B ;
NAIR, CP .
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1986, 13 (01) :66-69
[9]   Microglia: active sensor and versatile effector cells in the normal and pathologic brain [J].
Hanisch, Uwe-Karsten ;
Kettenmann, Helmut .
NATURE NEUROSCIENCE, 2007, 10 (11) :1387-1394
[10]   Amyotrophic lateral sclerosis [J].
Hardiman, Orla ;
Al-Chalabi, Ammar ;
Chio, Adriano ;
Corr, Emma M. ;
Logroscino, Giancarlo ;
Robberecht, Wim ;
Shaw, Pamela J. ;
Simmons, Zachary ;
van den Berg, Leonard H. .
NATURE REVIEWS DISEASE PRIMERS, 2017, 3